Authors: SMALL JG HIRSCH SR ARVANITIS LA MILLER BG LINK CGG MURPHY AL BOWDEN CL OBRIEN CP STEINBOOK RM WAGNER RL PITTS WM CRABTREE B CORRIGAN MHN LOHR JB MILLER AL ERESHEFSKY L ANDERSON CB KNESEVICH MA ROTROSEN J OWEN RR KARSON CN LINDENMAYER JP PFEFFERBAUM A FAUSTMAN WO KECK PE PATTERSON WM RIESENBERG RA GLADSON MB KOLIN IS BARNES TRE SENSKY T RICCIO M FRANKS S JOLLEY A HALLSTROM C BENNIE E DARCOURT G PATRIS M DESILVA M PATEL AG FLEISCHHACKER WW DIETZEL M SEIFERTOVA D VINAR O FALTUS F BITTER I OZSVATH K SHAW SH MAHAPATRA SN SZULECKA TK SUNDARARAJAN K CREAVEN F LYNCH J KLIESER E COOPER SJ ASCHAUER H

Citation: Jg. Small et al., QUETIAPINE IN PATIENTS WITH SCHIZOPHRENIA - A HIGH-DOSE AND LOW-DOSE DOUBLE-BLIND COMPARISON WITH PLACEBO, Archives of general psychiatry, 54(6), 1997, pp. 549-557

Authors: VOLZ HP FALTUS F MAGYAR I MOLLER HJ

Citation: Hp. Volz et al., BROFAROMINE IN TREATMENT-RESISTANT DEPRESSED-PATIENTS - A COMPARATIVETRIAL VERSUS TRANYLCYPROMINE, Journal of affective disorders, 30(3), 1994, pp. 209-217